BAILRIGG DIAGNOSTICS LIMITEDActive
Key figures
Like most small UK companies, BAILRIGG DIAGNOSTICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023/24Balance sheet structure
Filed accounts2019/20–2023/24
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2023/24 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 934 | 15,072 | — | — | — |
| Total assets | 11,083 | 25,578 | 13,450 | 15,575 | 10,525 |
| Total liabilities | 101,721 | 128,581 | 121,989 | 119,920 | 119,920 |
| Net assets / total equity | -69,221 | -71,300 | 108,539 | 104,345 | 109,395 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: BAILRIGG DIAGNOSTICS LIMITED
Company
BAILRIGG DIAGNOSTICS LIMITED is a private limited company registered with Companies House under company number 07938920. It was incorporated on 7 Feb 2012. Its status is active. The registered office is in Lancaster (LA1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2023/24 (period ending 27 Aug 2024); the company files micro-entity accounts. Net assets were £109,395, up 4.8% on the previous year. Total assets were £10,525 and total liabilities £119,920. The company had an average of 0 employees. Figures are available for 5 financial years (2019/20–2023/24).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 16 Nov 2026. The next confirmation statement is due by 21 Feb 2027.